34. 神経線維腫症 Neurofibromatosis Clinical trials / Disease details

臨床試験数 : 133 / 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04166409 (ClinicalTrials.gov)	January 3, 2020	15/11/2019	A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma	A Phase 3 Randomized Non-Inferiority Study of Carboplatin and VincristineVersus Selumetinib (NSC# 74 ...	Low Grade Astrocytoma;Low Grade Glioma;Metastatic Low Grade Astrocytoma;Metastatic Low Grade Glioma	Procedure: Biospecimen Collection;Drug: Carboplatin;Procedure: Magnetic Resonance Imaging;Other: Qua ...	National Cancer Institute (NCI)	NULL	Recruiting	2 Years	21 Years	All	220	Phase 3	United States;Canada;Puerto Rico
2	NCT03871257 (ClinicalTrials.gov)	October 4, 2019	11/3/2019	A Study of the Drugs Selumetinib Versus Carboplatin/Vincristinein Patients With Neurofibromatosis an ...	A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristinein Newly Diagnosed or Previo ...	Low Grade Glioma;Neurofibromatosis Type 1;Visual Pathway Glioma	Drug: Carboplatin;Procedure: Magnetic Resonance Imaging;Other: Quality-of-Life Assessment;Other: Que ...	National Cancer Institute (NCI)	NULL	Recruiting	2 Years	21 Years	All	290	Phase 3	United States;Canada;Puerto Rico
3	NCT00846430 (ClinicalTrials.gov)	October 2008	16/1/2009	Medical Treatment of High-Risk Neurofibromas	Medical Treatment of High-Risk Neurofibromas in Patients With Type 1 Neurofibromatosis: A Clinical T ...	Neurofibromatosis 1	Drug: Peg-Interferon alpha-2b;Drug: Celecoxib (Celebrex);Drug: Temozolomide (temodar);Drug: Vincristin ...	Spectrum Health Hospitals	NULL	Completed	2 Years	30 Years	All	11	Phase 2	United States

First Previous1Next Last